This HTML5 document contains 42 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
n7http://dx.doi.org/10.1200/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n8http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q73181702
rdf:type
wikibase:Item
schema:description
wetenschappelijk artikel наукова стаття, опублікована в серпні 1999 im August 1999 veröffentlichter wissenschaftlicher Artikel artículu científicu espublizáu n'agostu de 1999 scientific article published on 01 August 1999
p:P577
wds:Q73181702-9E255EEF-260F-4B29-B920-B76E69140B25
wdt:P577
1999-08-01T00:00:00Z
p:P407
wds:Q73181702-3E8CE8C9-7F52-4E6E-B79D-A51EDBF68AB2
wdt:P407
wd:Q1860
p:P2093
wds:Q73181702-09B756F6-5DF2-45BD-983F-BA4726E4F94D wds:Q73181702-DBC2E724-E619-460E-9B16-8D0E80612A96 wds:Q73181702-B4523C7B-7944-497B-8239-63AF94060D79
wdt:P2093
D A Vena B Freidlin J Barrett
rdfs:label
Second malignancies as a consequence of nucleoside analog therapy for chronic lymphoid leukemias Second malignancies as a consequence of nucleoside analog therapy for chronic lymphoid leukemias
skos:prefLabel
Second malignancies as a consequence of nucleoside analog therapy for chronic lymphoid leukemias Second malignancies as a consequence of nucleoside analog therapy for chronic lymphoid leukemias
schema:name
Second malignancies as a consequence of nucleoside analog therapy for chronic lymphoid leukemias Second malignancies as a consequence of nucleoside analog therapy for chronic lymphoid leukemias
p:P50
wds:Q73181702-ECAA17C2-1FDF-41EB-9A10-C8122446BDB9
wdt:P50
wd:Q88248387
p:P1476
wds:Q73181702-21091FE8-47D7-4C96-919C-114E4E5CD948
wdt:P1476
Second malignancies as a consequence of nucleoside analog therapy for chronic lymphoid leukemias
p:P304
wds:Q73181702-949A9B18-73AB-4D98-B93E-4684C2F362B9
wdt:P304
2454-2460
p:P31
wds:Q73181702-D938254B-9AAD-4B95-A6F2-7239D6BE493E
wdt:P31
wd:Q13442814
p:P698
wds:Q73181702-7A1A9B97-140C-4E98-955D-91FADBD93385
wdtn:P698
n8:10561309
wdt:P698
10561309
p:P1433
wds:Q73181702-65CEBDF8-AF7A-4C53-9999-B37E2E57285C
wdt:P1433
wd:Q400292
p:P433
wds:Q73181702-5F571B02-AF39-4EB4-8A26-50A783F53C92
p:P478
wds:Q73181702-FDE3BB64-DF85-4D36-ABC2-371DCABF2F50
wdt:P433
8
wdt:P478
17
p:P356
wds:Q73181702-573E6B86-2C86-4274-9A70-6918C774F4AE
wdtn:P356
n7:JCO.1999.17.8.2454
wdt:P356
10.1200/JCO.1999.17.8.2454